Volkmann Xandra, Anstaett Matthias, Hadem Johannes, Stiefel Penelope, Bahr Matthias J, Lehner Frank, Manns Michael P, Schulze-Osthoff Klaus, Bantel Heike
Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
Hepatology. 2008 May;47(5):1624-33. doi: 10.1002/hep.22237.
Acute liver failure (ALF) has various causes and is characterized by rapid hepatocyte dysfunction with development of encephalopathy in the absence of preexisting liver disease. Whereas most patients require liver transplantation to prevent the high mortality, some patients recover spontaneously and show complete liver regeneration. Because of the low incidence of ALF, however, the molecular mechanisms of liver dysfunction and regeneration are largely unknown. In this study, we investigated the role of apoptosis and caspases in 70 ALF patients using novel biomarkers that allow the detection of caspase activation in serum samples. Compared with healthy individuals, activation of caspases was strongly enhanced in ALF patients. Interestingly, patients with spontaneous recovery from ALF revealed a significantly higher activation of caspases than patients that required transplantation or died, although in the latter patients extensive DNA fragmentation and signs of nonapoptotic cell death were observed. In the spontaneous survivors, increased caspase activation was accompanied by elevated levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6), important cytokines involved in liver regeneration.
Our data suggest that caspase activation and apoptosis are involved in ALF of patients with spontaneous recovery, whereas caspase-independent cell death might be more relevant in irreversible forms of liver failure. These findings might be important for therapeutic options of ALF but also suggest that measurement of caspase activation might be of prognostic value to predict the outcome of acute liver failure.
急性肝衰竭(ALF)病因多样,其特征为肝细胞功能迅速失调,并在无既往肝病的情况下出现肝性脑病。尽管大多数患者需要肝移植以防止高死亡率,但一些患者可自发恢复并实现完全肝再生。然而,由于ALF发病率较低,肝功能障碍和再生的分子机制在很大程度上尚不清楚。在本研究中,我们使用能够检测血清样本中半胱天冬酶激活的新型生物标志物,研究了70例ALF患者中细胞凋亡和半胱天冬酶的作用。与健康个体相比,ALF患者中半胱天冬酶的激活显著增强。有趣的是,从ALF中自发恢复的患者显示出比需要移植或死亡的患者更高的半胱天冬酶激活水平,尽管在后者患者中观察到广泛的DNA片段化和非凋亡性细胞死亡迹象。在自发存活者中,半胱天冬酶激活增加伴随着肿瘤坏死因子α(TNF-α)和白细胞介素-6(IL-6)水平升高,这两种是参与肝再生的重要细胞因子。
我们的数据表明,半胱天冬酶激活和细胞凋亡参与了自发恢复患者的ALF,而不依赖半胱天冬酶的细胞死亡可能与不可逆形式的肝衰竭更为相关。这些发现可能对ALF的治疗选择很重要,但也表明半胱天冬酶激活的测量可能对预测急性肝衰竭的结果具有预后价值。